Integra Lifesciences Holdings Corp
IART
Market Cap$1.3B
Close$
$25.47
97.6% upside
Current Fair Value
97.6% upsideUndervalued by 97.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.30 Billion |
|---|---|
| Enterprise Value | $3.05 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.09 |
| Beta | 1.25 |
| Outstanding Shares | 77,010,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -186.9 |
|---|---|
| PEG | 9290.46 |
| Price to Sales | 0.64 |
| Price to Book Ratio | 0.64 |
| Enterprise Value to Revenue | 1.89 |
| Enterprise Value to EBIT | 114.19 |
| Enterprise Value to Net Income | -440 |
| Total Debt to Enterprise | 0.65 |
| Debt to Equity | 1.29 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Integra Lifesciences Holdings Corp
CEO: Peter Arduini